{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:18:48Z","timestamp":1785928728130,"version":"3.56.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.drudis.2022.103431","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T13:10:32Z","timestamp":1667826632000},"page":"103431","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting strategies for modulating pre-mRNA splicing with small molecules: Recent advances"],"prefix":"10.1016","volume":"28","author":[{"given":"Scott J.","family":"Barraza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew G.","family":"Woll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.103431_b0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.drudis.2022.103431_b0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nsmb.1718","article-title":"Human PRP4 kinase is required for stable tri-snRNP association during spliceosomal B complex formation","volume":"17","author":"Schneider","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0020","doi-asserted-by":"crossref","first-page":"e1005768","DOI":"10.1371\/journal.pgen.1005768","article-title":"Prp4 kinase grants the license to splice: control of weak splice sites during spliceosome activation","volume":"12","author":"Eckert","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.drudis.2022.103431_b0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/381080a0","article-title":"Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I","volume":"381","author":"Rossi","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2022.103431_b0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.1460-2075.1996.tb00357.x","article-title":"The Clk\/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution","volume":"15","author":"Colwill","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2022.103431_b0035","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1128\/MCB.19.10.6991","article-title":"L Manley James, The protein kinase Clk\/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing","volume":"19","author":"Prasad","year":"1999","journal-title":"Molecular Cellular Biology"},{"key":"10.1016\/j.drudis.2022.103431_b0040","article-title":"CLK1 reorganizes the splicing factor U1\u201370K for early spliceosomal protein assembly","volume":"118","author":"Aubol Brandon","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2022.103431_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/bj3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.drudis.2022.103431_b0050","doi-asserted-by":"crossref","first-page":"e0233672","DOI":"10.1371\/journal.pone.0233672","article-title":"An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications","volume":"15","author":"Shi","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2022.103431_b0055","doi-asserted-by":"crossref","first-page":"12728","DOI":"10.1038\/srep12728","article-title":"Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ","volume":"5","author":"Sonamoto","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2022.103431_b0060","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.chembiol.2020.08.013","article-title":"Mechanism-based personalized medicine for cystic fibrosis by suppressing pseudo exon inclusion","volume":"27","author":"Shibata","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0065","doi-asserted-by":"crossref","first-page":"eaau1682","DOI":"10.1126\/science.aau1682","article-title":"Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target","volume":"365","author":"Alam Mahmood","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103431_b0070","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1021\/acs.jmedchem.0c00451","article-title":"Development of potent PfCLK3 inhibitors based on TCMDC-135051 as a new class of antimalarials","volume":"63","author":"Mahindra","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0075","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1073\/pnas.1415525112","article-title":"Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia","volume":"112","author":"Yoshida","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2022.103431_b0080","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41467-021-24705-5","article-title":"Therapeutic manipulation of IKBKAP mis\u2013splicing with a small molecule to cure familial dysautonomia","volume":"12","author":"Ajiro","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.18632\/aging.202301","article-title":"Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression","volume":"13","author":"Chandra","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.drudis.2022.103431_b0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cellsig.2005.02.005","article-title":"Role of CDK\/cyclin complexes in transcription and RNA splicing","volume":"17","author":"Loyer","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.drudis.2022.103431_b0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrg3662","article-title":"Coupling mRNA processing with transcription in time and space","volume":"15","author":"Bentley","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.drudis.2022.103431_b0100","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.jmb.2016.04.017","article-title":"Coupling of RNA polymerase II transcription elongation with pre-mRNA splicing","volume":"428","author":"Saldi","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1097-2765(01)80002-2","article-title":"RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo","volume":"3","author":"Misteli","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.drudis.2022.103431_b0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/15476286.2021.1983287","article-title":"Inhibition of CDK9 activity compromises global splicing in prostate cancer cells","volume":"18","author":"Hu","year":"2021","journal-title":"RNA Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41419-020-02971-3","article-title":"CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells","volume":"11","author":"\u0160t\u011btkov\u00e1","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.drudis.2022.103431_b0120","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1172\/JCI82534","article-title":"Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth","volume":"126","author":"Dewaele","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.drudis.2022.103431_b0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (the writers, the readers and the erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.drudis.2022.103431_b0130","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/sj.onc.1207484","article-title":"The RNA binding protein Sam68 is acetylated in tumor cell lines, and its acetylation correlates with enhanced RNA binding activity","volume":"23","author":"Babic","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2022.103431_b0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00439-006-0186-1","article-title":"The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA\/protein levels in spinal muscular atrophy cells","volume":"120","author":"Riessland","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.drudis.2022.103431_b0140","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/hmg\/ddi205","article-title":"Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy","volume":"14","author":"Jarecki","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.drudis.2022.103431_b0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1261\/rna.1332609","article-title":"Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation","volume":"15","author":"Kuhn","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.drudis.2022.103431_b0150","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2019-131020","article-title":"PRMT5 is a key epigenetic regulator that promotes transcriptional activation in mantle cell lymphoma by regulating the lysine methyltransferase SETD7 and MLL1 activity","volume":"134","author":"Chung","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2022.103431_b0155","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/onc.2016.287","article-title":"Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2022.103431_b0160","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1093\/emboj\/cdf585","article-title":"Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs","volume":"21","author":"Meister","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2022.103431_b0165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41594-019-0313-z","article-title":"PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia","volume":"26","author":"Radzisheuskaya","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0170","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1101\/gad.219899.113","article-title":"Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery","volume":"27","author":"Bezzi","year":"2013","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2022.103431_b0175","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1535-7163.MCT-21-0367","article-title":"Discovery and pharmacological characterization of JNJ-64619178, a novel small-molecule inhibitor of PRMT5 with potent antitumor activity","volume":"20","author":"Brehmer","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2022.103431_b0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-21-0620","article-title":"SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance","volume":"21","author":"Jensen-Pergakes","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2022.103431_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2020.12.010","article-title":"MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage","volume":"39","author":"Kalev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2022.103431_b0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1101\/gad.247361.114","article-title":"Detained introns are a novel, widespread class of post-transcriptionally spliced introns","volume":"29","author":"Boutz","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.drudis.2022.103431_b0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ccell.2017.08.018","article-title":"Coordinated splicing of regulatory detained introns within oncogenic transcripts creates an exploitable vulnerability in malignant glioma","volume":"32","author":"Braun","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drudis.2022.103431_b0200","doi-asserted-by":"crossref","first-page":"23302","DOI":"10.1074\/jbc.C600143200","article-title":"Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing","volume":"281","author":"Donahue","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0205","doi-asserted-by":"crossref","first-page":"15134","DOI":"10.1074\/jbc.274.21.15134","article-title":"5\u2019 splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10","volume":"274","author":"Grover","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0210","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/cbic.201402069","article-title":"Bottom-up design of small molecules that stimulate exon 10 skipping in mutant MAPT pre-mRNA","volume":"15","author":"Luo","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.drudis.2022.103431_b0215","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nchembio.1452","article-title":"Sequence-based design of bioactive small molecules that target precursor microRNAs","volume":"10","author":"Velagapudi","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0220","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1021\/jacs.0c00768","article-title":"Design, optimization, and study of small molecules that target tau Pre-mRNA and affect splicing","volume":"142","author":"Chen","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.drudis.2022.103431_b0225","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1093\/nar\/gky565","article-title":"MBNL splicing activity depends on RNA binding site structural context","volume":"46","author":"Taylor","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2022.103431_b0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nchembio.2251","article-title":"Precise small-molecule recognition of a toxic CUG RNA repeat expansion","volume":"13","author":"Rzuczek","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0235","doi-asserted-by":"crossref","first-page":"7799","DOI":"10.1073\/pnas.1901484116","article-title":"Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model","volume":"116","author":"Angelbello","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2022.103431_b0240","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/acsmedchemlett.1c00027","article-title":"Massively parallel optimization of the linker domain in small molecule dimers targeting a toxic r(CUG) repeat expansion","volume":"12","author":"Vezina-Dawod","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2022.103431_b0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chembiol.2020.10.007","article-title":"A small molecule that binds an RNA repeat expansion stimulates its decay via the exosome complex","volume":"28","author":"Angelbello","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0250","doi-asserted-by":"crossref","first-page":"14305","DOI":"10.1002\/chem.202001572","article-title":"The dimeric form of 1,3-diaminoisoquinoline derivative rescued the mis-splicing of Atp2a1 and Clcn1 genes in myotonic dystrophy type 1 mouse model","volume":"26","author":"Matsumoto","year":"2020","journal-title":"Chem Eur J"},{"key":"10.1016\/j.drudis.2022.103431_b0255","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1021\/acs.jmedchem.1c00414","article-title":"A druglike small molecule that targets r(CCUG) repeats in myotonic dystrophy type 2 facilitates degradation by RNA quality control pathways","volume":"64","author":"Wagner-Griffin","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0260","doi-asserted-by":"crossref","first-page":"648133","DOI":"10.3389\/fnins.2021.648133","article-title":"Insight into spinocerebellar ataxia type 31 (SCA31) from Drosophila model","volume":"15","author":"Ishiguro","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2022.103431_b0265","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajhg.2009.09.019","article-title":"Spinocerebellar ataxia type 31 is associated with \u2018inserted\u2019 penta-nucleotide repeats containing (TGGAA)n","volume":"85","author":"Sato","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.drudis.2022.103431_b0270","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41467-020-20487-4","article-title":"Small molecule targeting r(UGGAA)n disrupts RNA foci and alleviates disease phenotype in Drosophila model","volume":"12","author":"Shibata","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuron.2007.07.021","article-title":"RNA-binding proteins hnRNP A2\/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS","volume":"55","author":"Sofola","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2022.103431_b0280","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/emboj.2010.21","article-title":"Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients","volume":"29","author":"Sellier","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.drudis.2022.103431_b0285","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.celrep.2013.02.004","article-title":"Sequestration of DROSHA and DGCR8 by expanded CGG RNA repeats alters microRNA processing in fragile X-associated tremor\/ataxia syndrome","volume":"3","author":"Sellier","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2022.103431_b0290","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/acschembio.7b00699","article-title":"Myricetin reduces toxic level of CAG repeats RNA in Huntington\u2019s disease (HD) and spino cerebellar ataxia (SCAs)","volume":"13","author":"Khan","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0295","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1007\/s12035-021-02697-z","article-title":"Small molecule screening discovers compounds that reduce FMRpolyG protein aggregates and splicing defect toxicity in fragile X-associated tremor\/ataxia syndrome","volume":"59","author":"Verma","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2022.103431_b0300","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1158\/1535-7163.MCT-17-0030","article-title":"Quercetin targets hnRNPA1 to overcome enzalutamide resistance in prostate cancer cells","volume":"16","author":"Tummala","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.drudis.2022.103431_b0305","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/molecules24040763","article-title":"Computer-aided discovery of small molecules targeting the RNA splicing activity of hnRNP A1 in castration-resistant prostate cancer","volume":"24","author":"Carabet","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2022.103431_b0310","doi-asserted-by":"crossref","first-page":"125414","DOI":"10.1016\/j.jhazmat.2021.125414","article-title":"Triclosan regulates alternative splicing events of nerve-related genes through RNA-binding protein CELF2 to induce zebrafish neurotoxicity","volume":"413","author":"Wang","year":"2021","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.drudis.2022.103431_b0315","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41467-020-19514-1","article-title":"Identification of phenothiazine derivatives as UHM\u2013binding inhibitors of early spliceosome assembly","volume":"11","author":"Jagtap","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0320","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/febs.16199","article-title":"Identification of a small molecule splicing inhibitor targeting UHM domains","volume":"289","author":"Kobayashi","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.drudis.2022.103431_b0325","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.chembiol.2021.02.007","article-title":"A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex","volume":"28","author":"Chatrikhi","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0330","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.12.2.283","article-title":"Indisulam: an anticancer sulfonamide in clinical development","volume":"12","author":"Supuran","year":"2003","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.drudis.2022.103431_b0335","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/jm9902638","article-title":"Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle","volume":"42","author":"Owa","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0340","doi-asserted-by":"crossref","first-page":"eaal3755","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.drudis.2022.103431_b0345","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.celrep.2019.09.079","article-title":"Aryl sulfonamides degrade RBM39 and RBM23 by recruitment to CRL4-DCAF15","volume":"29","author":"Ting","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.drudis.2022.103431_b0350","doi-asserted-by":"crossref","first-page":"115712","DOI":"10.1016\/j.bmc.2020.115712","article-title":"The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells","volume":"28","author":"Melnyk","year":"2020","journal-title":"Biorg Med Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0355","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41589-019-0411-6","article-title":"Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex","volume":"16","author":"Bussiere","year":"2020","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0360","doi-asserted-by":"crossref","first-page":"e1381","DOI":"10.1002\/wrna.1381","article-title":"Modulating splicing with small molecular inhibitors of the spliceosome","volume":"8","author":"Effenberger","year":"2017","journal-title":"WIREs RNA"},{"key":"10.1016\/j.drudis.2022.103431_b0365","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1038\/s41467-021-27157-z","article-title":"Small molecule splicing modifiers with systemic HTT-lowering activity","volume":"12","author":"Bhattacharyya","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0375","first-page":"E4604","article-title":"G Schultz Peter, A Johnson Kristen, Mechanistic studies of a small-molecule modulator of SMN2 splicing","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.drudis.2022.103431_b0380","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-017-01559-4","article-title":"Binding to SMN2 pre-mRNA\u2013protein complex elicits specificity for small molecule splicing modifiers","volume":"8","author":"Sivaramakrishnan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0385","unstructured":"PRNewswire, PTC Therapeutics Announces Initiation of PIVOT-HD Phase 2 Clinical Trial to Evaluate PTC518 in Patients with Huntington\u2019s Disease, 2022. https:\/\/ir.ptcbio.com\/news-releases\/news-release-details\/ptc-therapeutics-announces-initiation-pivot-hd-phase-2-clinical [Accessed November 1, 2022]."},{"key":"10.1016\/j.drudis.2022.103431_b0390","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1007\/s00018-020-03493-z","article-title":"The SF3b complex: splicing and beyond","volume":"77","author":"Sun","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.drudis.2022.103431_b0395","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nchembio.2007.18","article-title":"Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA","volume":"3","author":"Kaida","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0400","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B\u20138800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.drudis.2022.103431_b0405","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0410","doi-asserted-by":"crossref","first-page":"11222","DOI":"10.3390\/ijms222011222","article-title":"Investigating the molecular mechanism of H3B\u20138800: a splicing modulator inducing preferential lethality in spliceosome-mutant cancers","volume":"22","author":"Spinello","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2022.103431_b0415","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B\u20138800 in myeloid neoplasms","volume":"35","author":"Steensma","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2022.103431_b0420","article-title":"The thiazole-5-carboxamide GPS491 inhibits HIV-1, adenovirus, and coronavirus replication by altering RNA processing\/accumulation","volume":"14","author":"Dahal","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.drudis.2022.103431_b0425","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/acsmedchemlett.1c00428","article-title":"2-Trifluoromethylthiazole-5-carboxamides: analogues of a stilbene-based anti-HIV agent that impact HIV mRNA processing","volume":"12","author":"Zamiri","year":"2021","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2022.103431_b0430","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1093\/nar\/gkt727","article-title":"Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function","volume":"41","author":"Wong","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.drudis.2022.103431_b0435","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/acsmedchemlett.1c00396","article-title":"Discovery of small-molecule CD33 pre-mRNA splicing modulators","volume":"13","author":"Chappie","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.drudis.2022.103431_b0440","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1038\/s41467-020-18765-2","article-title":"Selective inhibition of human translation termination by a drug-like compound","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0445","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.chembiol.2016.08.016","article-title":"A small-molecule anti-secretagogue of PCSK9 targets the 80S ribosome to inhibit PCSK9 protein translation","volume":"23","author":"Petersen","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.omtm.2020.11.011","article-title":"Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts","volume":"20","author":"Buratti","year":"2021","journal-title":"Mol Therapy - Methods Clin Develop"},{"key":"10.1016\/j.drudis.2022.103431_b0455","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/acs.bioconjchem.6b00291","article-title":"Natural product splicing inhibitors: a new class of antibody\u2013drug conjugate (ADC) payloads","volume":"27","author":"Puthenveetil","year":"2016","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.drudis.2022.103431_b0460","doi-asserted-by":"crossref","first-page":"e0240718","DOI":"10.1371\/journal.pone.0240718","article-title":"Synergistic apoptotic effects in cancer cells by the combination of CLK and Bcl-2 family inhibitors","volume":"15","author":"Murai","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2022.103431_b0465","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1021\/acschembio.9b00833","article-title":"Splice modulation synergizes cell cycle inhibition","volume":"15","author":"Trieger","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.drudis.2022.103431_b0470","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41467-021-23663-2","article-title":"A deep learning approach to identify gene targets of a therapeutic for human splicing disorders","volume":"12","author":"Gao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0475","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2472555218792264","article-title":"Development of a screening platform to identify small molecules that modify ELP1 Pre-mRNA splicing in familial dysautonomia","volume":"24","author":"Salani","year":"2019","journal-title":"SLAS Discov"},{"key":"10.1016\/j.drudis.2022.103431_b0480","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/s41467-020-16806-4","article-title":"CRISPR artificial splicing factors","volume":"11","author":"Du","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.drudis.2022.103431_b0485","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41586-021-03770-2","article-title":"Regulated control of gene therapies by drug-induced splicing","volume":"596","author":"Monteys","year":"2021","journal-title":"Nature"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462200424X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462200424X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:03:07Z","timestamp":1761224587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462200424X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S135964462200424X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103431","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting strategies for modulating pre-mRNA splicing with small molecules: Recent advances","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103431","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103431"}}